See more : Therma Bright Inc. (TBRIF) Income Statement Analysis – Financial Results
Complete financial analysis of Alpha Healthcare Acquisition Corp. (AHACU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alpha Healthcare Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Tulsyan NEC Limited (TULSYAN.BO) Income Statement Analysis – Financial Results
- FirstCash Holdings, Inc (FCFS) Income Statement Analysis – Financial Results
- The Karnataka Bank Limited (KTKBANK.BO) Income Statement Analysis – Financial Results
- Copper Fox Metals Inc. (CUU.V) Income Statement Analysis – Financial Results
- Kobe Bussan Co., Ltd. (3038.T) Income Statement Analysis – Financial Results
Alpha Healthcare Acquisition Corp. (AHACU)
About Alpha Healthcare Acquisition Corp.
Alpha Healthcare Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 1.57M | 1.26M | 1.49M | 6.19M |
| Cost of Revenue | 76.55M | 8.26M | 49.00K | 8.43M | 75.60M |
| Gross Profit | -76.55M | -6.69M | 1.21M | -6.94M | -69.42M |
| Gross Profit Ratio | 0.00% | -427.48% | 96.12% | -465.53% | -1,121.97% |
| Research & Development | 76.55M | 63.26M | 61.34M | 54.08M | 75.60M |
| General & Administrative | 23.39M | 22.88M | 21.13M | 12.01M | 16.27M |
| Selling & Marketing | -3.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.39M | 22.88M | 21.13M | 12.01M | 16.27M |
| Other Expenses | -73.44M | -1.57M | -1.26M | -1.49M | 0.00 |
| Operating Expenses | 23.50M | 84.58M | 81.21M | 64.60M | 16.28M |
| Cost & Expenses | 100.05M | 84.58M | 81.21M | 64.60M | 91.88M |
| Interest Income | 0.00 | 2.63M | 16.00K | 278.00K | 269.00K |
| Interest Expense | 1.13M | 6.20M | 4.35M | 2.20M | 2.30M |
| Depreciation & Amortization | 7.72M | 8.26M | 8.28M | 8.43M | 6.75M |
| EBITDA | -96.46M | 2.49M | -72.97M | -56.25M | -78.94M |
| EBITDA Ratio | 0.00% | -10,245.69% | -10,845.61% | -3,753.92% | -1,275.93% |
| Operating Income | -100.05M | -84.58M | -81.21M | -64.60M | -85.69M |
| Operating Income Ratio | 0.00% | -5,404.35% | -6,429.77% | -4,332.66% | -1,385.02% |
| Total Other Income/Expenses | -10.73M | 72.61M | 54.73M | -1.92M | 269.00K |
| Income Before Tax | -110.78M | -11.97M | -26.48M | -66.52M | -85.42M |
| Income Before Tax Ratio | 0.00% | -764.54% | -2,096.36% | -4,461.70% | -1,380.67% |
| Income Tax Expense | 0.00 | -76.18M | -64.01M | 2.20M | 0.00 |
| Net Income | -110.78M | 64.22M | 37.54M | -68.73M | -85.42M |
| Net Income Ratio | 0.00% | 4,103.45% | 2,971.97% | -4,609.39% | -1,380.67% |
| EPS | -1.07 | 0.62 | 0.94 | -5.52 | -4.25 |
| EPS Diluted | -1.07 | 0.62 | 0.94 | -5.52 | -4.25 |
| Weighted Avg Shares Out | 103.42M | 103.05M | 39.97M | 12.45M | 20.12M |
| Weighted Avg Shares Out (Dil) | 103.42M | 103.05M | 39.97M | 12.45M | 20.12M |
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Alpha Healthcare Acquisition Corp. - AHAC
NEW YORK, March 27, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State...
Regenerative Tissue Developer Humacyte Going Public Via SPAC
Humacyte is a leader in regenerative medicine, growing human tissue in the lab that can be transplanted into any patient.
Alpha Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing November 9, 2020
NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (the “Company”) announced today that holders of the units sold in the Company's initial public offering of 10,000,000 units completed on September 22, 2020 (the “offering”) may elect...
Source: https://incomestatements.info
Category: Stock Reports